Zidovudine exposure in HIV-1 infected Tanzanian women increases mitochondrial DNA levels in placenta and umbilical cords

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Kunz, Andrea ^a   von Wurmb Schwark, Nicole ^b   Sewangi, Julius ^c   Ziske, Judith ^a   Lau, Inga ^a   Mbezi, Paulina ^c   Theuring, Stefanie ^a   Hauser, Andrea ^a,d   Dugange, Festo ^e   Katerna, Angela ^b   Harms, Gundel ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^d ROBERT KOCH INSTITUTE   (Germany)

^e Kyela District Hospital   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; MITOCHONDRIAL DNA; NEVIRAPINE; ZIDOVUDINE;

ADULT; ARTICLE; BASE PAIRING; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE DELETION; GENE FREQUENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL TOXICITY; PRENATAL DRUG EXPOSURE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; TANZANIA;

ADULT; ANTI-HIV AGENTS; DNA, MITOCHONDRIAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; PLACENTA; PREGNANCY; TANZANIA; UMBILICAL CORD; YOUNG ADULT; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84864584463     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041637     Document Type: Article

References (71)

1. World Health Organization (2010) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Recommendations for a public health approach. 2010 version. WHO website. Available: http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf. Accessed 2012 Jul 3.
2. Chen CH, Vazquez-Padua M, Cheng YC,((1991)) Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol 39:: 625--628.
3. Kamemoto LE, Shiramizu B, Gerschenson M,((2004)) HIV-associated mitochondrial toxicity in pregnancy. Mitochondrion 4:: 153--162.
4. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, et al.((1990)) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J 322:: 1098--1105.
5. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, et al.((1991)) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337:: 508--510.
6. Gerschenson M, Poirier MC,((2000)) Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure. Ann N Y Acad Sci 918:: 269--281.
7. Gerschenson M, Nguyen V, Ewings EL, Ceresa A, Shaw JA, et al.((2004)) Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine. AIDS Res Hum Retroviruses 20:: 91--100.
8. Divi RL, Leonard SL, Walker BL, Kuo MM, Shockley ME, et al.((2007)) Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age. Toxicol Sci 99:: 203--213.
9. Divi RL, Leonard SL, Kuo MM, Nagashima K, Thamire C, et al.((2007)) Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Environ Mol Mutagen 48:: 201--209.
10. Divi RL, Einem TL, Fletcher SL, Shockley ME, Kuo MM, et al.((2010)) Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs). Toxicol Sci 118:: 191--201.
11. Lim SE, Copeland WC,((2001)) Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J Biol Chem 276:: 23616--23623.
12. Samuels DC,((2006)) Mitochondrial AZT metabolism. IUBMB Life 58:: 403--408.
13. Lewis W, Copeland WC, Day BJ,((2001)) Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors. Lab Invest 81:: 777--790.
14. Côté HC,((2005)) Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy. Antivir Ther 10:: M3--11.
15. Lund KC, Wallace KB,((2008)) Adenosine 3′,5′-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors. Toxicol Appl Pharmacol 226:: 94--106.
16. Scruggs ER, Dirks Naylor AJ,((2008)) Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy. Pharmacology 82:: 83--88.
17. Höschele D,((2006)) Cell culture models for the investigation of NRTI-induced mitochondrial toxicity. Relevance for the prediction of clinical toxicity. Toxicol In Vitro 20:: 535--546.
18. Aldrovandi GM, Chu C, Shearer WT, Li D, Walter J, et al.((2009)) Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women. Pediatrics 124:: e1189--1197.
19. Casula M, Bosboom-Dobbelaer I, Smolders K, Otto S, Bakker M, et al.((2005)) Infection with HIV-1 induces a decrease in mtDNA. J Infect Dis 191:: 1468--1471.
20. Miró O, López S, Martínez E, Pedrol E, Milinkovic A, et al.((2004)) Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. Clin Infect Dis 39:: 710--716.
21. Miura T, Goto M, Hosoya N, Odawara T, Kitamura Y, et al.((2003)) Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy. J Med Virol 70:: 497--505.
22. Arnoult D, Viollet L, Petit F, Lelièvre JD, Estaquier J,((2004)) HIV-1 triggers mitochondrion death. Mitochondrion 4:: 255--269.
23. Barret B, Tardieu M, Rustin P, Lacroix C, Chabrol B, et al.((2003)) Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 17:: 1769--1785.
24. The Perinatal Safety Review Working Group((2000)) Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J Acquir Immune Defic Syndr 25:: 261--268.
25. European Collaborative Study,((2003)) Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 32:: 380--387.
26. Shiramizu B, Shikuma KM, Kamemoto L, Gerschenson M, Erdem G, et al.((2003)) Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 32:: 370--374.
27. McComsey GA, Kang M, Ross AC, Lebrecht D, Livingston E, et al.((2008)) Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy. HIV Clin Trials 9:: 126--136.
28. Divi RL, Walker VE, Wade NA, Nagashima K, Seilkop SK, et al.((2004)) Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir. AIDS 18:: 1013--1021.
29. Poirier MC, Divi RL, Al-Harthi L, Olivero OA, Nguyen V, et al.((2003)) Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr 33:: 175--183.
30. Torres SM, Walker DM, McCash CL, Carter MM, Ming J, et al.((2009)) Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT-based therapies for prophylaxis of HIV-1. Environ Mol Mutagen 50:: 10--26.
31. Williams PL, Marino M, Malee K, Brogly S, Hughes MD, et al.((2010)) Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants. Pediatrics 125:: e250--260.
32. Arnheim N, Cortopassi G,((1992)) Deleterious mitochondrial DNA mutations accumulate in aging human tissues. Mutat Res 275:: 157--167.
33. Kirsten I, Sewangi J, Kunz A, Dugange F, Ziske J, et al.((2011)) Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania. PLoS One 6:: e21020.
34. World Health Organization (2006) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Towards universal access: Recommendations for a public health approach. 2006 version. WHO website. Available: http://www.who.int/hiv/pub/guidelines/pmtctguidelines3.pdf. Accessed 2012 Jul 3.
35. The United Republic of Tanzania, Ministry of Health and Social Welfare (2007) Prevention of Mother-To-Child Transmission of HIV (PMTCT), National Guidelines. Dar es Salaam, Tanzania: Ministry of Health and Social Welfare. Website of the National AIDS Control Program Tanzania. Available: http://www.nacp.go.tz/documents/PMTCT%20GUIDELINES%202007.pdf. Accessed 2012 Jul 3.
36. Gross NJ, Getz GS, Rabinowitz M,((1969)) Apparent turnover of mitochondrial deoxyribonucleic acid and mitochondrial phospholipids in the tissues of the rat. J Biol Chem 244:: 1552--1562.
37. Hauser A, Sewangi J, Mbezi P, Dugange F, Lau I, et al.((2012)) Emergence of Minor Drug-Resistant HIV-1 Variants after Triple Antiretroviral Prophylaxis for Prevention of Vertical HIV-1 Transmission. PLoS One 7 (2):: e32055.
38. Von Wurmb-Schwark N, Ringleb A, Schwark T, Broese T, Weirich S, et al.((2008)) The effect of chronic alcohol consumption on mitochondrial DNA mutagenesis in human blood. Mutat Res 637:: 73--79.
39. Wong A, Cortopassi G,((2002)) Reproducible quantitative PCR of mitochondrial and nuclear DNA copy number using the LightCycler. Methods Mol Biol 197:: 129--137.
40. Von Wurmb-Schwark N, Higuchi R, Fenech AP, Elfstroem C, Meissner C, et al.((2002)) Quantification of human mitochondrial DNA in a real time PCR. Forensic Sci Int 126:: 34--39.
41. Meissner C, von Wurmb N,((1998)) Sensitive detection of the 4977 bp Deletion in human mitochondrial DNA of young individuals. BioTechniques 25:: 652--654.
42. Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, et al.((2006)) Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients. Antivir Ther 11:: 601--608.
43. Rabing Christensen E, Stegger M, Jensen-Fangel S, Laursen AL, Ostergaard L,((2004)) Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study. Clin Infect Dis 39:: 1371--1379.
44. Casula M, Weverling GJ, Wit FW, Timmermans EC, Stek M Jr, et al.((2005)) Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy. J Infect Dis 192:: 1794--1800.
45. Kurauchi O, Furui T, Tanaka M, Mizutani S, Ozawa T, et al.((1995)) The study of mitochondrial gene modifications in human placenta. Placenta 16:: 461--467.
46. Furui T, Kurauchi O, Tanaka M, Mizutani S, Ozawa T, et al.((1994)) Decrease in cytochrome c oxidase and cytochrome oxidase subunit I messenger RNA levels in preeclamptic pregnancies. Obstet Gynecol 84:: 283--288.
47. Zhang YF,((2007)) Age-dependent mitochondrial DNA 4977bp depletion in human skeletal muscle. Fa Yi Xue Za Zhi 23:: 438--440.
48. Liu VW, Zhang C, Nagley P,((1998)) Mutations in mitochondrial DNA accumulate differentially in three different human tissues during ageing. Nucleic Acids Res 26:: 1268--1275.
49. Nádasi EA, Melegh B, Seress L, Kosztolányi G,((2003)) Mitochondrial DNA4977 deletion in brain of newborns died after intensive care. Acta Biol Hung 54:: 253--262.
50. Fromenty B, Grimbert S, Mansouri A, Beaugrand M, Erlinger S, et al.((1995)) Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology 108:: 193--200.
51. Fahn HJ, Wang LS, Kao SH, Chang SC, Huang MH, et al.((1998)) Smoking-associated mitochondrial DNA mutations and lipid peroxidation in human lung tissues. Am J Respir Cell Mol Biol 19:: 901--909.
52. Iwai K, Iwamura Y, Yamashita S, Wadano Y, Mesaki N,((2006)) Effect of tea catechins on mitochondrial DNA 4977-bp deletions in human leucocytes. Mutat Res 595:: 191--195.
53. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, et al.((2000)) T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 96:: 3866--3871.
54. Olivetta E, Percario Z, Fiorucci G, Mattia G, Schiavoni I, et al.((2003)) HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation. J Immunol 170:: 1716--1727.
55. Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, et al.((1992)) Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol 66:: 7159--7167.
56. Lee BN, Ordonez N, Popek EJ, Lu JG, Helfgott A, et al.((1997)) Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells. J Virol 71:: 3628--3635.
57. Shearer WT, Reuben J, Lee BN, Popek EJ, Lewis DE, et al.((1997)) Role of placental cytokines and inflammation in vertical transmission of HIV infection. Acta Paediatr. Suppl 421pp. 33--38.
58. Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, et al.((2003)) Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107:: 1418--1423.
59. Suliman HB, Welty-Wolf KE, Carraway MS, Schwartz DA, Hollingsworth JW, et al.((2005)) Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J 19:: 1531--1533.
60. Kim J, Xu M, Xo R, Mates A, Wilson GL, et al.((2010)) Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes. Osteoarthritis Cartilage 18:: 424--432.
61. Pornprasert S, Faye A, Mary JY, Dolcini G, Leechanachai P, et al.((2006)) Down modulation of TNF-alpha mRNA placental expression by AZT used for the prevention of HIV-1 mother-to-child transmission. Placenta 27:: 989--995.
62. Saitoh A, Fenton T, Alvero C, Fletcher CV, Spector SA,((2007)) Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy. Antimicrob Agents Chemother 51:: 4236--4242.
63. Banas B, Kost BP, Goebel FD,((2004)) Platelets, a typical source of error in real-time PCR quantification of mitochondrial DNA content in human peripheral blood cells. Eur J Med Res 9:: 371--377.
64. Pinti M, Salomoni P, Cossarizza A,((2006)) Anti-HIV drugs and the mitochondria. Biochim Biophys Acta 1757:: 700--707.
65. Hendrickson SL, Kingsley LA, Ruiz-Pesini E, Poole JC, Jacobson LP, et al.((2009)) Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 51:: 111--116.
66. Yamanaka H, Gatanaga H, Kosalaraksa P, Matsuoka-Aizawa S, Takahashi T, et al.((2007)) Novel mutation of human DNA polymerase gamma associated with mitochondrial toxicity induced by anti-HIV treatment. J Infect Dis 195:: 1419--1425.
67. Bailey CM, Kasiviswanathan R, Copeland WC, Anderson KS,((2009)) R964C mutation of DNA polymerase gamma imparts increased stavudine toxicity by decreasing nucleoside analog discrimination and impairing polymerase activity. Antimicrob Agents Chemother 53:: 2610--2612.
68. Canter JA, Haas DW, Kallianpur AR, Ritchie MD, Robbins GK, et al.((2008)) The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy. Pharmacogenomics J 8:: 71--77.
69. Hulgan T, Haas DW, Haines JL, Ritchie MD, Robbins GK, et al.((2005)) Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19:: 1341--1349.
70. Hulgan T, Haubrich R, Riddler SA, Tebas P, Ritchie MD, et al.((2011)) European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142. AIDS 25:: 37--47.
71. Wallace DC, Brown MD, Lott MT,((1999)) Mitochondrial DNA variation in human evolution and disease. Gene 238:: 211--230.